SQSTM1 and metabolic dysfunction-associated steatotic liver disease: Significantly decreased expression of lysosomal enzymes (cathepsin B, D, and L) in the livers of MASLD patients supports the hypothesis of impaired autophagy, as an accumulation of p62/SQSTM1 indicates dysfunctional lysosomal degradation of autophagic cargo.